Boehringer, Teva Slam Aggrenox Buyers' Doc Production
Boehringer Ingelheim and Teva on Friday told a Connecticut federal judge that the direct purchasers accusing them in multidistrict litigation of scheming to keep generic versions of the stroke-prevention drug Aggrenox...To view the full article, register now.
Already a subscriber? Click here to view full article